JP2019507113A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507113A5 JP2019507113A5 JP2018534626A JP2018534626A JP2019507113A5 JP 2019507113 A5 JP2019507113 A5 JP 2019507113A5 JP 2018534626 A JP2018534626 A JP 2018534626A JP 2018534626 A JP2018534626 A JP 2018534626A JP 2019507113 A5 JP2019507113 A5 JP 2019507113A5
- Authority
- JP
- Japan
- Prior art keywords
- biodegradable
- disease
- antigen
- subject
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021105106A JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2025136021A JP2025181835A (ja) | 2016-01-04 | 2025-08-18 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662274711P | 2016-01-04 | 2016-01-04 | |
| US62/274,711 | 2016-01-04 | ||
| PCT/US2017/012173 WO2017120222A1 (en) | 2016-01-04 | 2017-01-04 | Particles encapsulating fusion proteins containing linked epitopes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021105106A Division JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507113A JP2019507113A (ja) | 2019-03-14 |
| JP2019507113A5 true JP2019507113A5 (https=) | 2020-02-06 |
| JP6904959B2 JP6904959B2 (ja) | 2021-07-21 |
Family
ID=59274014
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018534626A Active JP6904959B2 (ja) | 2016-01-04 | 2017-01-04 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2021105106A Active JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A Active JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2025136021A Pending JP2025181835A (ja) | 2016-01-04 | 2025-08-18 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021105106A Active JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A Active JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2025136021A Pending JP2025181835A (ja) | 2016-01-04 | 2025-08-18 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20190365656A1 (https=) |
| EP (1) | EP3400069A4 (https=) |
| JP (4) | JP6904959B2 (https=) |
| CA (1) | CA3009799A1 (https=) |
| IL (2) | IL260296B2 (https=) |
| WO (1) | WO2017120222A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| KR102233251B1 (ko) | 2013-04-03 | 2021-03-26 | 엔-폴드 엘엘씨 | 신규 나노입자 조성물 |
| EP3247384B1 (en) * | 2015-01-14 | 2023-10-04 | The Regents of the University of Colorado, a body corporate | In vitro method of diagnosis of type 1 diabetes with insulin mimotopes |
| GB201508025D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Fabry disease gene therapy |
| WO2017201210A1 (en) | 2016-05-18 | 2017-11-23 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| ES2973548T3 (es) | 2016-12-22 | 2024-06-20 | Cue Biopharma Inc | Polipéptidos multiméricos moduladores de linfocitos T y métodos para su uso |
| EP3565829A4 (en) | 2017-01-09 | 2021-01-27 | Cue Biopharma, Inc. | T-CELL-MODULATING MULTIMERIC POLYPEPTIDES AND METHOD OF USING THEREOF |
| US20200010528A1 (en) | 2017-03-15 | 2020-01-09 | Cue Biopharma, Inc. | Methods for modulating an immune response |
| CN111566214B (zh) * | 2017-07-06 | 2024-03-08 | 日东纺绩株式会社 | 抗人IgG4单克隆抗体及利用该抗体的人IgG4测定试剂 |
| EP3678677A4 (en) * | 2017-09-07 | 2021-06-16 | Cue Biopharma, Inc. | Antigen-presenting polypeptides and methods of use thereof |
| JPWO2019131769A1 (ja) * | 2017-12-26 | 2021-02-12 | 公立大学法人名古屋市立大学 | 新規抗ｐａｄ４抗体 |
| CN111886241A (zh) | 2018-01-09 | 2020-11-03 | 库尔生物制药有限公司 | 多聚体t细胞调节多肽及其使用方法 |
| CN110041408B (zh) * | 2018-01-16 | 2021-05-18 | 华中科技大学 | 一种小分子多肽及其在制备防治帕金森综合症药物中的应用 |
| US11679146B2 (en) | 2018-06-05 | 2023-06-20 | Anji Pharmaceuticals Inc. | Compositions and methods for treating pancreatitis |
| JP7523358B2 (ja) * | 2018-06-13 | 2024-07-26 | アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニ | ムスカリン受容体ｍ３に対して阻害活性を有するペプチド |
| US20230001010A1 (en) * | 2019-07-19 | 2023-01-05 | The Regents Of The University Of Michigan | Compositions and methods for treating autoimmune disorders |
| EP4138907A4 (en) * | 2020-04-20 | 2024-08-21 | The General Hospital Corporation | IMMUNOGENIC COMPOSITION OF CORONAVIRUS WITH EPITOPES HAVING HIGH NETWORK SCORE |
| WO2021231376A2 (en) | 2020-05-12 | 2021-11-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| IT202000010888A1 (it) * | 2020-05-13 | 2021-11-13 | Consiglio Nazionale Ricerche | Nanovescicole di mielina e loro impieghi |
| WO2022056014A1 (en) | 2020-09-09 | 2022-03-17 | Cue Biopharma, Inc. | Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereof |
| GB202017119D0 (en) * | 2020-10-28 | 2020-12-09 | Oxford Vacmedix Uk Ltd | Polypeptides for cancer treatment |
| KR20230171998A (ko) | 2021-04-16 | 2023-12-21 | 코어 파마슈티칼스 디벨롭먼트 컴퍼니 인크. | 면역학적 관용의 유지를 추적하는 방법 |
| JP2024518565A (ja) * | 2021-05-11 | 2024-05-01 | オックスフォード ヴァクメディックス ユーケー リミテッド | 組換え重複ペプチド及びネイティブタンパク質を含むワクチン製剤 |
| US20250084126A1 (en) * | 2021-07-07 | 2025-03-13 | Osaka University | Peptide and composition |
| WO2023070104A1 (en) | 2021-10-21 | 2023-04-27 | Cour Pharmaceuticals Development Company Inc. | Treatment of primary biliary cholangitis (pbc) with tolerizing nanoparticles |
| EP4436557A4 (en) * | 2021-11-24 | 2025-06-11 | Cour Pharmaceuticals Development Company Inc. | PRODUCTION OF TOLERANT NANOPARTICLES FOR THE TREATMENT OF PEANUT ALLERGY |
| AU2023238308A1 (en) * | 2022-03-24 | 2024-10-10 | Julius-Maximilians-Universität Würzburg | Mhc ib-mediated islet-antigen-specific immunosuppression as a novel treatment for type 1 diabetes |
| JP2025515424A (ja) | 2022-04-29 | 2025-05-15 | クール ファーマシューティカルズ ディベロップメント カンパニー インコーポレイテッド | 治療用ベクター及びタンパク質の免疫原性を克服するための寛容化免疫改変ナノ粒子 |
| CN115541872A (zh) * | 2022-09-22 | 2022-12-30 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种pd-l1检测试剂盒及其检测方法 |
| EP4604999A1 (en) | 2022-10-19 | 2025-08-27 | Cour Pharmaceuticals Development Company Inc. | Treatment of peanut allergy with tolerizing nanoparticles |
| CN115771883B (zh) * | 2022-11-28 | 2024-02-23 | 淮阴工学院 | 从酿酒酵母发酵液中提取的蛋白酶a在化学法合成纳米硒形貌控制和稳定性影响中的用途 |
| TW202444434A (zh) | 2023-03-24 | 2024-11-16 | 美商庫爾製藥發展公司股份有限公司 | 用於重症肌無力治療之免疫修飾奈米粒子之處理 |
| KR20260016937A (ko) | 2023-05-23 | 2026-02-04 | 코어 파마슈티칼스 디벨롭먼트 컴퍼니 인크. | 원발성 담즙성 담관염의 치료를 위한 관용화 나노입자의 제조 |
| IL324854A (en) | 2023-05-25 | 2026-01-01 | Cour Pharmaceuticals Dev Company Inc | Treatment of type 1 diabetes (t1d) with tolerizing nanoparticles |
| WO2025027015A1 (en) * | 2023-08-01 | 2025-02-06 | Diamante Srl | Composition and methods for treating multiple sclerosis |
| WO2025043196A2 (en) * | 2023-08-24 | 2025-02-27 | The Trustees Of Indiana University | Anti-cancer peptides, and methods and uses thereof |
| WO2025199149A1 (en) | 2024-03-18 | 2025-09-25 | Cour Pharmaceuticals Development Company Inc. | Sting agonism for antigen specific tolerance |
| WO2026019942A2 (en) | 2024-07-16 | 2026-01-22 | Cour Pharmaceuticals Development Company Inc. | Tolerizing immune modifying nanoparticles for treatment of narcolepsy |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200102423T2 (tr) * | 1998-12-04 | 2002-02-21 | Biogen, Inc. | Peptid ligandları yoluyla bağlı birden fazla imünojenik bileşeni olan HBV çekirdek antijeni parçacıkları |
| US20020131960A1 (en) * | 2000-06-02 | 2002-09-19 | Michel Sadelain | Artificial antigen presenting cells and methods of use thereof |
| US20060222656A1 (en) * | 2005-04-01 | 2006-10-05 | University Of Maryland, Baltimore | MAGE-A3/HPV 16 peptide vaccines for head and neck cancer |
| US8071561B2 (en) * | 2007-08-16 | 2011-12-06 | Chrontech Pharma Ab | Immunogen platform |
| EP2571992B1 (en) * | 2010-05-21 | 2018-04-25 | Merrimack Pharmaceuticals, Inc. | Bi-specific fusion proteins |
| JP2013538211A (ja) * | 2010-08-23 | 2013-10-10 | セレクタ バイオサイエンシーズ インコーポレーテッド | 抗原に対する免疫反応を誘発する標的マルチエピトープ剤形 |
| KR102181258B1 (ko) * | 2012-02-16 | 2020-11-20 | 브이엘피 테라퓨틱스 엘엘씨 | 바이러스 유사 입자 조성물 |
| CN110064049B (zh) * | 2012-06-21 | 2024-02-09 | 西北大学 | 肽缀合粒子 |
| KR20160042079A (ko) * | 2013-08-13 | 2016-04-18 | 노쓰웨스턴유니버시티 | 펩티드-접합된 입자 |
| WO2017139498A1 (en) * | 2016-02-09 | 2017-08-17 | Cour Pharmaceuticals Development Company Inc. | Timps encapsulating japanese cedar pollen epitopes |
-
2017
- 2017-01-04 EP EP17736249.8A patent/EP3400069A4/en active Pending
- 2017-01-04 WO PCT/US2017/012173 patent/WO2017120222A1/en not_active Ceased
- 2017-01-04 US US16/067,867 patent/US20190365656A1/en not_active Abandoned
- 2017-01-04 CA CA3009799A patent/CA3009799A1/en active Pending
- 2017-01-04 JP JP2018534626A patent/JP6904959B2/ja active Active
- 2017-01-04 IL IL260296A patent/IL260296B2/en unknown
-
2021
- 2021-06-24 JP JP2021105106A patent/JP7333360B2/ja active Active
-
2023
- 2023-06-12 US US18/333,103 patent/US20240122864A1/en active Pending
- 2023-07-19 IL IL304580A patent/IL304580A/en unknown
- 2023-08-14 JP JP2023132166A patent/JP7730867B2/ja active Active
-
2025
- 2025-08-18 JP JP2025136021A patent/JP2025181835A/ja active Pending